Sartopore 2 MidiCaps,0,2µm,BH9,4pcs, Sartopore® 2 MidiCaps, 1231,27 CHF

cookie name	sample content	expiration time
_ga_*	deleted	730 days
_ga	GA1.1.8643343795.1726666186	730 days

Sartopore 2 Membrane Filters MidiCaps are self-contained, ready-to-use, sterile filter elements for sterile filtration in the pharmaceutical | biotech industry. Due to their hydrophilic, heterogeneous, double-layer polyethersulfone membrane, Sartopore 2 capsules are suitable for sterile filtration of a diverse range of pharmaceutical products. Applications: Typical applications include sterile filtration of: - Therapeutics - Biological fluids - Infusions - Media - Buffers - Chemicals - Detergents and disinfectants. Compatibility: The polyethersulfone membrane is compatible in a range of pH 1 to 14, making Sartopore 2 MidiCaps ideal for filtration of low | high pH solutions. Easy handling: Sartopore 2 MidiCaps are shipped as individually packaged sterile elements, avoiding on-site sterilisation prior to use. Flexibility: Sartopore 2 0.2 µm MidiCaps are available with different filtration areas from 500 cm² | 0.5 ft² to 0.45 m² | 5 ft² for easy adaptation to any filtration process regardless of batch size. Scalability: Consistent and predictable scale-up and scale-down processes can be performed with operational confidence because all Sartopore 2 MidiCaps are manufactured with the same membrane type and identical materials of construction. Cost savings: By using single-use filter elements, there is no need to invest in stainless steel filter housings. Additional costs for cleaning the housings and cleaning validation are eliminated. Microbiological retention: Sartopore 2 MidiCaps 0.2 µm are fully validated sterile filter elements according to HIMA and ASTM F-838-05 guidelines. Quality control: Each individual filter element is tested for integrity in a batch-related single-unit test using diffusion and bubble-point tests. Documentation: Sartopore 2 MidiCaps are designed, developed and manufactured in accordance with the ISO 9001 certified quality management system. A validation manual is available in accordance with regulatory requirements. Single-Use MidiCaps® for Process Scale Reduction in Cleaning & Cleaning Validation Superior Flow & Life Economical Process Solution Broad Chemical Compatibility Applications: Typical applications include sterile filtration of: Therapeutka - Biological fluids - Injection solutions - Media - Buffers - Chemicals - Cleaning and disinfecting agents. Compatibility: The polyethersulfone membrane is compatible in a range of pH 1 to 14, making Sartopore® 2 MidiCaps® ideal for filtration of low | high pH solutions. Easy handling: Sartopore® 2 MidiCaps are supplied as individually sterile-packed, ready-to-use units, eliminating the need for sterilisation prior to use. Flexibility: Sartopore® 2 0.2 µm MidiCaps® are available with different filtration areas from 500 cm² | 0.5 ft² to 0.45 m² | 5 ft² for easy adaptation to any filtration process regardless of batch size. Scale Up: Consistent and predictable scale-up and scale-down procedures can be performed with operational confidence because all Sartopore® 2 MidiCaps® are manufactured with the same membrane type and identical materials of construction. Cost savings: By using single-use filter elements, there is no need to invest in stainless steel filter housings. Additional costs for cleaning the housings and cleaning validation are eliminated. Microbiological retention: Sartopore® 2 MidiCaps® 0.2 µm are fully validated sterile filter elements according to HIMA and ASTM F-838-05 guidelines. Quality control: Each individual element is tested for integrity to meet the highest quality requirements. Documentation: Sartopore® 2 MidiCaps are designed, developed and manufactured in accordance with the ISO 9001 certified quality management system. A validation manual is available in accordance with regulatory requirements. Sartopore 2 MidiCaps, 0.2µm, size9, 4pc, Sartopore® 2 MidiCaps® 0.2µm

Product safety information

Manufacturer information:

Sartorius

, ,

There are no reviews yet.